App that reads your mood and fights cravings put to the test

NCT ID NCT03538652

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a smartphone app designed to help people with opioid addiction by sending helpful messages at just the right moment. Nine adults who used heroin or other opioids carried a phone that beeped four times a day to ask about their mood and activities, then showed a message based on their answers. The goal was to see whether different types of messages (like problem-solving or mindfulness) worked better in different situations. The study was terminated early, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

smartphone app with cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT) messages

What this could lead to

If successful, this could point toward more effective, personalized smartphone tools to help people manage cravings and moods during addiction recovery.

What could go wrong

This was a very small, early-stage study that was terminated early, so results are limited. The app's effectiveness remains unproven, and it may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institute on Drug Abuse

    Baltimore, Maryland, 21224, United States